KCTD12: A Comprehensive Research Report

Gene Identity Summary

• Gene Symbol: KCTD12 (also known as PFET1, C13orf2, KIAA1778)
• Protein Name: BTB/POZ domain-containing protein KCTD12 (also known as Pfetin)
• UniProt Accession: Q96CX2
• Organism: Homo sapiens (Human)
• Chromosomal Location: 13q21
• Key Domains: BTB/POZ domain (T1-type), H1 domain

Introduction

KCTD12 (potassium channel tetramerization domain-containing protein 12) is a cytosolic protein that functions as an auxiliary subunit of GABA_B receptors (gamma-aminobutyric acid type B receptors) in the mammalian central nervous system. Originally identified as PFET1 (predominantly fetal expressed T1 domain) through subtractive hybridization of human fetal cochlear cDNA, this protein was initially characterized based on its voltage-gated potassium channel tetramerization (T1) domain and its predominant expression in fetal tissues, particularly the cochlea and brain [resendes-2004-jaro-abstract]. The discovery that KCTD12 and related family members (KCTD8, KCTD12b, and KCTD16) function as auxiliary subunits of GABA_B receptors represented a paradigm shift in understanding GABA_B receptor biology, revealing that these receptors are not simple heterodimers but rather macromolecular complexes with auxiliary proteins that determine their pharmacology and signaling kinetics [schwenk-2010-nature-abstract].

The primary function of KCTD12 is to modulate GABA_B receptor signaling by influencing receptor surface expression, G-protein coupling efficiency, and response kinetics. Most notably, KCTD12 uniquely induces rapid desensitization of GABA_B receptor-activated potassium currents, a property that distinguishes it from other KCTD family members [turecek-2014-neuron-abstract]. This molecular function has profound implications for neuronal excitability, synaptic transmission, and has been linked to neuropsychiatric disorders including bipolar disorder, major depression, and schizophrenia [cathomas-2015-transl-psych-abstract].

Discovery and Original Characterization

KCTD12 was first identified and characterized by Resendes and colleagues in 2004 as a novel intronless gene with predominant fetal expression. Using subtractive hybridization and differential screening of human fetal cochlear cDNA libraries, they isolated PFET1 (approved symbol KCTD12) and its mouse homolog Pfet1 [resendes-2004-jaro-abstract]. The gene encodes a transcript of approximately 6 kb with a 978 bp open reading frame in humans, producing a predicted 325 amino acid protein containing a voltage-gated potassium channel tetramerization (T1) domain. The gene is intronless with an unusually long 3' untranslated region (4996 bp) containing multiple polyadenylation signals. KCTD12 maps to human chromosome 13q21 and mouse chromosome 14 [resendes-2004-jaro-abstract].

The original immunohistochemistry studies revealed pfetin (the KCTD12 protein product) expression in various cell types in human, monkey, mouse, and guinea pig cochlea and vestibular system, including type I vestibular hair cells and cochlear fibrocytes. Given the cellular distribution within the cochlea, investigators initially hypothesized that pfetin might play a role in ion transport or potassium recycling, consistent with the presence of the T1 domain characteristic of potassium channel subunits [resendes-2004-jaro-abstract]. However, the major functional breakthrough came with proteomic studies that identified KCTD12 as an auxiliary subunit of GABA_B receptors rather than a component of potassium channels proper.

Identification as GABA_B Receptor Auxiliary Subunit

The landmark 2010 study by Schwenk et al. in Nature fundamentally changed the understanding of GABA_B receptor composition and KCTD12 function. Using proteomic analysis of native GABA_B receptors, they demonstrated that functional receptors are not simple heterodimers of GABA_B1 and GABA_B2 subunits, but rather high-molecular-mass complexes that include members of the KCTD protein family [schwenk-2010-nature-abstract]. Four KCTD proteins—KCTD8, KCTD12, KCTD12b, and KCTD16—were identified as auxiliary receptor subunits that associate as tetramers or pentamers with the carboxy terminus of GABA_B2.

These KCTD proteins are cytosolic proteins that increase agonist potency at GABA_B receptors and markedly alter G-protein signaling. All four KCTDs accelerate the onset of the potassium current response, but KCTD12 and KCTD12b uniquely induce desensitization [schwenk-2010-nature-abstract]. This discovery established KCTD12 as an auxiliary subunit that determines the pharmacology and kinetics of the GABA_B receptor response throughout the brain.

Subsequent high-resolution proteomic analysis in 2016 further refined the understanding of native GABA_B receptor architecture. Schwenk et al. demonstrated that the receptor core consists of GABA_B1a/b, GABA_B2, four KCTD proteins, and a distinct set of G-protein subunits [schwenk-2016-nat-neurosci-abstract]. These complexes also associate with various transmembrane proteins including voltage-gated calcium channels (Ca_v2), hyperpolarization-activated cyclic nucleotide-gated channels (HCN), and AJAP1 and amyloid-β A4 proteins. This modular composition underlies the functional diversity observed in native GABA_B responses across different brain regions and neuronal populations.

Molecular Mechanism of KCTD12 Function

Receptor Surface Stabilization

KCTD12 constitutively associates with GABA_B receptors beginning in the endoplasmic reticulum and maintains stable association throughout receptor trafficking, activation, and internalization cycles. Ivankova et al. (2013) demonstrated using bimolecular fluorescence complementation, metabolic labeling, and biotinylation assays that GABA_B receptors associate with KCTD12 while they reside in the endoplasmic reticulum [ivankova-2013-jbc-abstract]. At the plasma membrane, KCTD12 reduces constitutive receptor internalization, thereby increasing the magnitude of receptor signaling at the cell surface. Genetic knockout or knockdown of KCTD12 in cultured hippocampal neurons reduces the magnitude of GABA_B receptor-mediated K+ current responses, confirming the physiological importance of this auxiliary subunit for receptor function.

Desensitization Mechanism

The most distinctive property of KCTD12 among the GABA_B receptor auxiliary subunits is its ability to induce rapid and pronounced desensitization of receptor-activated potassium currents. Turecek et al. (2014) elucidated the molecular mechanism underlying this property [turecek-2014-neuron-abstract]. KCTD12-induced desensitization results from a dual interaction with the G protein: constitutive binding stabilizes the heterotrimeric G protein at the receptor, whereas dynamic binding to the receptor-activated Gβγ subunits induces desensitization by uncoupling Gβγ from the effector potassium channel.

When GABA_B receptors are activated, the heterotrimeric G protein dissociates, releasing Gβγ subunits that normally activate GIRK (G protein-gated inwardly rectifying potassium) channels. KCTD12 sequesters these Gβγ subunits, preventing their continued interaction with GIRK channels and producing rapid current decay characteristic of desensitization. While free KCTD12 can desensitize K+ currents activated by other G protein-coupled receptors in vitro, native KCTD12 exclusively associates with GABA_B receptors, ensuring specificity of this regulatory mechanism [turecek-2014-neuron-abstract].

Structural Basis for Gβγ Sequestration

The structural basis for KCTD-mediated GABA_B receptor regulation was revealed by Zheng et al. (2019) using X-ray crystallography and electron microscopy [zheng-2019-nature-abstract]. They showed that KCTDs associate with the receptor by forming an asymmetric pentameric ring around a region of the receptor carboxy-terminal tail. A second KCTD domain, H1, engages in a symmetric interaction with five copies of Gβγ in which the G-protein subunits also interact directly with one another.

The crystal structure (PDB: 6M8S) of the KCTD12 H1 domain in complex with Gβ1γ2 subunits revealed a hetero 15-mer with cyclic C5 symmetry at 3.71 Å resolution. Critically, KCTD binding to Gβγ is highly cooperative, defining a model in which KCTD proteins cooperatively strip G proteins from GIRK channels to induce rapid desensitization following receptor activation [zheng-2019-nature-abstract]. Association of KCTD12 with a single GIRK-bound Gβγ subunit tethers KCTD12 to the membrane, allowing it to rapidly strip remaining Gβγ subunits from the activated channel. This cooperative mechanism provides a molecular explanation for the precise temporal control of GABA_B signaling by KCTD12.

The H1 domains in KCTD12 and KCTD12b contain a particular sequence motif (T/NFLEQ) that mediates desensitization through Gβγ binding. This motif is absent in KCTD8 and KCTD16, explaining why these family members do not induce desensitization [turecek-2014-neuron-abstract].

Protein Domain Architecture

KCTD12 possesses a modular domain architecture characteristic of the KCTD protein family. Biophysical characterization by Correale et al. (2013) revealed that KCTD12 contains two distinct folded domains: the N-terminal BTB domain (KCTD12BTB) and the C-terminal H1 domain (KCTD12H1) [correale-2013-jmr-abstract]. Secondary structure prediction and circular dichroism spectroscopy showed that the BTB domain assumes an α/β structure, whereas the H1 domain is predominantly characterized by β-structure. Both domains demonstrated independent tetrameric or pentameric organization with mutual binding affinity, suggesting a compact overall protein structure.

The BTB domain (also known as POZ domain) is the founding feature of this protein family and mediates oligomerization. Importantly, the BTB domain of KCTD12 forms an "open pentamer" in which two adjacent subunits of the C5 assembly do not form tight contacts. This opening is functionally important as it favors binding to the GABA_B2 receptor carboxy terminus. The interaction between KCTD12 and the GABA_B2 receptor C-terminal region occurs at low micromolar affinity [correale-2013-jmr-abstract].

AlphaFold structure predictions and experimental crystallography have confirmed the pentameric assembly of KCTD12 domains. The crystal structure of the KCTD12 H1 domain complexed with Gβ1γ2 (PDB: 6M8S) shows RMSD values of 0.63 Å against predicted structures, indicating high accuracy of computational predictions for this protein [zheng-2019-nature-abstract]. Due to the long unstructured linker segment between the BTB and H1 domains, predictions of full-length KCTD12 structure are not typically performed, and the domains are analyzed independently.

Subcellular Localization and Tissue Distribution

Subcellular Localization

KCTD12 is a cytosolic protein that lacks a transmembrane domain but associates with the plasma membrane through its interaction with GABA_B receptors. Electron microscopy studies demonstrate that KCTD12 concentrates in the somatodendritic compartment, consistent with primarily postsynaptic localization [metz-2011-jcn-abstract]. The protein associates almost exclusively with GABA_B receptors, with immunohistochemistry showing that KCTD12 localization closely follows GABA_B receptor distribution.

In neurons, KCTD12 associates with GABA_B receptors beginning in the endoplasmic reticulum and maintains this association through receptor trafficking to the plasma membrane and during receptor activation/deactivation cycles [ivankova-2013-jbc-abstract]. This constitutive assembly ensures that KCTD12 is positioned to modulate receptor signaling immediately upon agonist binding.

Brain Distribution

Metz et al. (2011) comprehensively characterized the regional distribution of KCTD12 and related auxiliary subunits in the mouse brain using in situ hybridization and immunohistochemistry [metz-2011-jcn-abstract]. Most neurons express KCTD transcripts, with KCTD12 and KCTD16 showing widespread expression while KCTD8 and KCTD12b demonstrate more restricted patterns. Individual neurons can coexpress multiple KCTDs, as observed in hippocampal granule cells and CA1/CA3 pyramidal cells.

KCTD12 shows particularly high expression in brain regions implicated in emotional processing and cognition, including the prefrontal cortex, amygdala, and hippocampus [cathomas-2015-transl-psych-abstract]. In the cortex, KCTD12 is strongly expressed in a large number of cells in the inner layers (predominantly layer VI) and in dispersed cells in the outer layers. This distribution pattern contrasts with KCTD16, which predominates in outer cortical layers [metz-2011-jcn-abstract].

KCTD12 has also been identified in hippocampal interneurons, particularly cholecystokinin-containing interneurons (CCK-INs), which express high dendritic GABA_B receptors paired with KCTD12 auxiliary proteins [booker-2017-cerebral-cortex-abstract]. In these cells, GABA_B receptor-mediated currents display strong desensitization that is absent in KCTD12-deficient mice.

Axonal Expression in the Habenulo-Interpeduncular Pathway

Recent studies have revealed an important role for KCTD12 in facilitating axonal expression of GABA_B receptors, particularly in the medial habenula (MHb) to interpeduncular nucleus (IPN) pathway. Ren et al. (2022) demonstrated that KCTD8 and KCTD12 facilitate axonal expression of GABA_B receptors in habenula cholinergic neurons [ren-2022-jneurosci-abstract]. Genetic knockout of KCTD8/12/16 or KCTD8/12 specifically substantially reduced GABA_B receptor-mediated potentiation of glutamate release and presynaptic Ca²⁺ entry at axonal terminals, while leaving somatic inhibition intact. Overexpressing either KCTD8 or KCTD12 in MHb neurons of knockout mice rescued axonal GABA_B expression and presynaptic excitation.

This pathway is particularly notable because GABA_B receptors mediate presynaptic excitation rather than inhibition in MHb terminals—a unique property in the brain. The enhancement of neurotransmission from medial habenula terminals by GABA_B receptor activation represents the strongest known potentiation of transmitter release in the central nervous system. Bhandari et al. (2021) showed that KCTD12 immunofluorescence appears strong in the rostral and central subnuclei of the IPN but faint in the lateral subnucleus, and that KCTD8 and KCTD12b (but not KCTD12) directly bind to Cav2.3 R-type calcium channels [bhandari-2021-elife-abstract]. This interaction modulates calcium-mediated transmitter release independently of GABA_B receptor signaling, revealing an additional mechanism by which KCTD proteins regulate synaptic transmission.

At the behavioral level, inactivating GABA_B receptors in habenula cholinergic neurons impairs the extinction of aversive memory in mice. In KCTD knockout animals, aversion-predicting cues produce stronger neuronal activation and GABA_B agonist treatment proves less effective for fear extinction [ren-2022-jneurosci-abstract]. These findings establish isoform-specific roles for KCTD proteins in enriching axonal receptor expression and modulating fear-related neural circuits.

Developmental Regulation

KCTD expression varies during development. KCTD16 is expressed earlier than KCTD12 and KCTD12b. The distinct spatial and temporal KCTD distribution patterns are proposed to underlie functional differences in native GABA_B responses across developmental stages and brain regions [metz-2011-jcn-abstract]. In humans, KCTD12 was originally identified as a gene with predominant fetal expression, with highest levels in fetal cochlea and brain but minimal detection in adult tissues [resendes-2004-jaro-abstract].

Peripheral Expression

According to the Human Protein Atlas, KCTD12 shows low tissue specificity across normal adult tissues, with elevated RNA expression in placenta, fallopian tube, adipose tissue, and smooth muscle. In the brain, highest expression is observed in spinal cord, medulla oblongata, and midbrain. At the cellular level, enhanced expression occurs in Kupffer cells, neuroendocrine cells, monocytes, macrophages, and vascular endothelial cells.

GABA_B Receptor Signaling Pathway

Overview of GABA_B Receptor Function

GABA (gamma-aminobutyric acid) mediates the majority of inhibitory neurotransmission in the mammalian brain. GABA_B receptors are G protein-coupled receptors that affect neuronal activity by activating heterotrimeric G proteins (G_i/o) that modulate the activity of potassium and calcium effector channels [gassmann-2012-nrn-abstract]. Presynaptic GABA_B receptors inhibit neurotransmitter release by reducing calcium channel activity, while postsynaptic receptors reduce neuronal excitability by activating GIRK channels that produce hyperpolarizing potassium currents. These mechanisms modulate synaptic plasticity and maintain excitation-inhibition balance throughout the brain.

Functional GABA_B receptors are obligate heterodimers consisting of GABA_B1 (which binds GABA) and GABA_B2 (which couples to G proteins) subunits. GABA_B1 exists in two main splice variants: GABA_B1a and GABA_B1b, which differ in their N-terminal domains and subcellular targeting [gassmann-2012-nrn-abstract].

KCTD12 Modulation of Receptor Kinetics

KCTD12 modulates GABA_B receptor function in several ways that distinguish it from other KCTD family members. Li et al. (2017) demonstrated that human KCTD12 co-expression alters the kinetics of GABA_B receptor-mediated GIRK channels, speeding both activation and desensitization [li-2017-prp2-abstract]. Specifically, the rise time of potassium currents decreases approximately two-fold (P < 0.001), and relative desensitization increases substantially from 4.54% to 54.7% (P < 0.001). These kinetic changes mirror those observed with mouse KCTD12 variants.

Importantly, KCTD12 enhances positive allosteric modulation by compounds like CGP7930. Potentiation increases from 10.8% to 21.7% with KCTD12 present, and CGP7930 shortens rise time and accelerates desensitization in KCTD12-expressing cells. However, concentration-response curves for GABA and baclofen show no significant differences between receptors with or without KCTD12, indicating the auxiliary protein does not alter agonist potency [li-2017-prp2-abstract].

Physiological and Behavioral Consequences

Mouse Knockout Studies

Studies using KCTD12 knockout mice have provided critical insights into the physiological functions of this auxiliary subunit. Cathomas et al. (2015) demonstrated that Kctd12+/− and Kctd12−/− mice exhibit altered emotional and homeostatic behaviors [cathomas-2015-transl-psych-abstract]. Complete knockout produces increased fear learning during auditory conditioning, with mice showing enhanced acquisition-phase freezing but paradoxically not increased fear memory expression. Heterozygous mice show hyperactivity specifically during the inactive phase of the circadian cycle.

Electrophysiological recordings from hippocampal slices revealed increased intrinsic excitability of CA1 pyramidal neurons in both knockout and heterozygous animals. The neurons exhibited reduced resting membrane conductance, lower rheobase current required for action potential generation, and decreased action potential delay [cathomas-2015-transl-psych-abstract]. Voltage-clamp analysis showed reduced tonic barium-sensitive potassium current in knockout neurons, suggesting KCTD12 generates tonic K+ current independent of GABA_B receptor activity. This represents the first direct evidence for KCTD12 involvement in determining phenotypes of emotionality, behavioral activity, and neuronal excitability.

Seizure Susceptibility and Ethanol Consumption

Li et al. (2017) examined additional behavioral phenotypes in KCTD12 knockout mice [li-2017-prp2-abstract]. The knockout mice demonstrated significantly reduced susceptibility to pentylenetetrazole-induced seizures, with only 2 of 11 knockout mice showing hind leg extension compared to 6 of 9 wild-type animals. This finding suggests that KCTD12 deletion resembles GABA_B receptor enhancement, consistent with the reduced desensitization expected when KCTD12 is absent.

In the two-bottle preference test, KCTD12 knockout mice consumed substantially less ethanol, particularly at higher concentrations. This reduced ethanol consumption at high concentrations aligns with known GABA_B receptor involvement in alcohol preference and reinforcement. These in vivo studies confirmed that KCTD12 deletion produces phenotypes consistent with enhanced GABA_B receptor function [li-2017-prp2-abstract].

Association with Neuropsychiatric Disorders

Genetic Associations

The KCTD12 gene has been linked to multiple neuropsychiatric disorders through genetic association studies. A genome-wide association study in the Han Chinese population identified a single nucleotide polymorphism in the promoter region of KCTD12 associated with increased prevalence of bipolar I disorder [teng-2019-cns-neurosci-ther-abstract]. Additionally, microarray studies show decreased KCTD12 expression in peripheral blood mononuclear cells (PBMCs) from individuals with chronic stress and schizophrenia patients.

Intriguingly, expression changes appear brain region-specific. In major depression patients and mice exposed to chronic unpredictable stress, amygdala tissue shows upregulated KCTD12 expression. Conversely, schizophrenia patients demonstrate reduced PBMC KCTD12 expression but increased postmortem hippocampal KCTD12 expression [cathomas-2015-transl-psych-abstract]. These findings suggest complex, region-specific roles for KCTD12 in different neuropsychiatric conditions.

Stress Response

The role of KCTD12 in stress-related disorders has been investigated in animal models. Chronic social defeat stress (CSDS) increases KCTD12 expression in the dentate gyrus of the hippocampus. Overexpression of KCTD12 in the dentate gyrus induces higher responsiveness to acute stress and increased vulnerability to social stress in mice, whereas knockdown of KCTD12 prevents social avoidance behavior. The GABA_B receptor antagonist CGP35348 improved stress-induced behavioral responses while suppressing excess KCTD12 expression, supporting a causal role for KCTD12-mediated GABA_B receptor modulation in stress responses [teng-2019-cns-neurosci-ther-abstract].

Lithium Regulation

Lithium, a key therapeutic agent for bipolar disorder, regulates KCTD12 expression through glycogen synthase kinase-3 (GSK-3) inhibition. Through GSK-3 inhibition, lithium induces cyclic AMP-response element binding protein (CREB)-mediated KCTD12 promoter activation. This finding suggests that KCTD12 may be an important gene with respect to neuronal excitability and lithium response in bipolar patients. Targeting GSK-3 activity and/or KCTD12 expression may constitute a possible therapeutic strategy for treating patients with bipolar disorder [teng-2019-cns-neurosci-ther-abstract].

Other Roles and Clinical Associations

Gastrointestinal Stromal Tumors

Beyond its neurological functions, KCTD12 has been identified as a diagnostic and prognostic biomarker for gastrointestinal stromal tumors (GIST). KCTD12 is negatively regulated by Kit in GISTs, suggesting involvement in oncogenic signaling pathways distinct from its GABA_B receptor auxiliary function. The protein has also been implicated in colorectal cancer cell stemness regulation through the ERK pathway, highlighting potential roles in cancer biology.

Cochlear Function

Given its original identification in fetal cochlea and expression in cochlear fibrocytes involved in potassium recycling, KCTD12 may play roles in auditory function. However, systematic studies of auditory phenotypes in KCTD12-deficient animals have not been extensively reported. The high KCTD12 expression in cell types implicated in cochlear potassium recycling suggests potential involvement in ion homeostasis, though the discovery of its GABA_B receptor auxiliary function now provides an alternative interpretation for its cochlear expression.

Open Questions

1. What is the precise stoichiometry of KCTD12 within native GABA_B receptor complexes? While structural studies have characterized KCTD12 pentamers, the actual subunit composition in different brain regions and cell types remains to be fully determined.

2. How does KCTD12 contribute to auditory function? Despite its original identification in cochlea, the physiological role of KCTD12 in hearing and vestibular function has not been systematically investigated using knockout models.

3. What therapeutic potential exists in targeting KCTD12 or its interaction interfaces? Given the association with neuropsychiatric disorders, developing modulators of KCTD12-GABA_B receptor or KCTD12-Gβγ interactions could provide novel therapeutic approaches.

4. What are the molecular mechanisms linking KCTD12 expression changes to neuropsychiatric phenotypes? The region-specific and context-dependent changes in KCTD12 expression in mood disorders suggest complex regulatory mechanisms that remain poorly understood.

5. How does KCTD12 cooperate with other KCTD family members in native receptors? Individual neurons can express multiple KCTDs, and their combinatorial effects on GABA_B receptor function require further investigation.

6. Does KCTD12 have functions independent of GABA_B receptors? The finding that KCTD12 generates tonic K+ current independent of GABA_B receptor activity suggests potential additional functions that warrant exploration.

7. What is the structural basis for KCTD12's exclusive association with GABA_B receptors? While free KCTD12 can interact with other GPCRs in vitro, native KCTD12 associates exclusively with GABA_B receptors through mechanisms that are not fully understood.

References

1. [resendes-2004-jaro-abstract] Resendes BL, Kuo SF, Robertson NG, Giersch ABS, Honrubia D, Ohara O, Adams JC, Morton CC. Isolation from cochlea of a novel human intronless gene with predominant fetal expression. J Assoc Res Otolaryngol. 2004 Jun;5(2):185-202. PMID: 15357420. DOI: 10.1007/s10162-003-4042-x. URL: https://pubmed.ncbi.nlm.nih.gov/15357420/

2. [schwenk-2010-nature-abstract] Schwenk J, Metz M, Zolles G, Turecek R, Fritzius T, Bildl W, Tarusawa E, Kulik A, Unger A, Ivankova K, Seddik R, Tiao JY, Rajalu M, Trojanova J, Rohde V, Gassmann M, Schulte U, Fakler B, Bettler B. Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits. Nature. 2010 May 13;465(7295):231-5. PMID: 20400944. DOI: 10.1038/nature08964. URL: https://www.nature.com/articles/nature08964

3. [turecek-2014-neuron-abstract] Turecek R, Schwenk J, Fritzius T, Ivankova K, Zolles G, Adelfinger L, Jacquier V, Besseyrias V, Gassmann M, Schulte U, Fakler B, Bettler B. Auxiliary GABAB receptor subunits uncouple G protein βγ subunits from effector channels to induce desensitization. Neuron. 2014 Jun 4;82(5):1032-44. PMID: 24836506. DOI: 10.1016/j.neuron.2014.04.015. URL: https://pubmed.ncbi.nlm.nih.gov/24836506/

4. [zheng-2019-nature-abstract] Zheng S, Abreu N, Levitz J, Kruse AC. Structural basis for KCTD-mediated rapid desensitization of GABAB signalling. Nature. 2019 Mar;567(7746):127-131. PMID: 30814734. PMCID: PMC6405316. DOI: 10.1038/s41586-019-0990-0. URL: https://www.nature.com/articles/s41586-019-0990-0

5. [ivankova-2013-jbc-abstract] Ivankova K, Turecek R, Fritzius T, Seddik R, Prezeau L, Comps-Agrar L, Pin JP, Fakler B, Besseyrias V, Gassmann M, Bettler B. Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12). J Biol Chem. 2013 Aug 23;288(34):24848-56. PMID: 23843457. DOI: 10.1074/jbc.M113.476770. URL: https://pubmed.ncbi.nlm.nih.gov/23843457/

6. [metz-2011-jcn-abstract] Metz M, Gassmann M, Fakler B, Schaeren-Wiemers N, Bettler B. Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain. J Comp Neurol. 2011 Jun 1;519(8):1435-54. PMID: 21452234. DOI: 10.1002/cne.22610. URL: https://pubmed.ncbi.nlm.nih.gov/21452234/

7. [cathomas-2015-transl-psych-abstract] Cathomas F, Stegen M, Sigrist H, Schmid L, Seifritz E, Gassmann M, Bettler B, Pryce CR. Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders. Transl Psychiatry. 2015 Feb 17;5:e510. PMID: 25689571. PMCID: PMC4445757. DOI: 10.1038/tp.2015.8. URL: https://www.nature.com/articles/tp20158

8. [gassmann-2012-nrn-abstract] Gassmann M, Bettler B. Regulation of neuronal GABAB receptor functions by subunit composition. Nat Rev Neurosci. 2012 Jun;13(6):380-94. PMID: 22531905. DOI: 10.1038/nrn3249. URL: https://www.nature.com/articles/nrn3249

9. [li-2017-prp2-abstract] Li R, Bhattarai KR, Vincent KF, Liu H, Chen Q. KCTD12 modulation of GABA(B) receptor function. Pharmacol Res Perspect. 2017 Jun;5(4):e00319. PMID: 28713569. PMCID: PMC5508304. DOI: 10.1002/prp2.319. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5508304/

10. [schwenk-2016-nat-neurosci-abstract] Schwenk J, Pérez-Garci E, Schneider A, Kollewe A, Gauthier-Kemper A, Fritzius T, Raveh A, Dinamarca MC, Hanuschkin A, Bildl W, Klingauf J, Gassmann M, Schulte U, Bettler B, Fakler B. Modular composition and dynamics of native GABAB receptors identified by high-resolution proteomics. Nat Neurosci. 2016 Feb;19(2):233-42. PMID: 26691831. DOI: 10.1038/nn.4198. URL: https://www.nature.com/articles/nn.4198

11. [booker-2017-cerebral-cortex-abstract] Booker SA, Althof D, Gross A, Loreth D, Müller J, Unger A, Fakler B, Varro A, Bhouri M, Vida I. KCTD12 Auxiliary Proteins Modulate Kinetics of GABAB Receptor-Mediated Inhibition in Cholecystokinin-Containing Interneurons. Cereb Cortex. 2017 Mar 1;27(3):2318-2334. PMID: 27073217. DOI: 10.1093/cercor/bhw090. URL: https://academic.oup.com/cercor/article/27/3/2318/3056328

12. [teng-2019-cns-neurosci-ther-abstract] Teng X, Aouacheria A, et al. KCTD: A new gene family involved in neurodevelopmental and neuropsychiatric disorders. CNS Neurosci Ther. 2019 Aug;25(8):887-902. PMID: 31197948. PMCID: PMC6566181. DOI: 10.1111/cns.13156. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC6566181/

13. [ren-2022-jneurosci-abstract] Ren Y, Liu Y, Zheng S, Luo M. KCTD8 and KCTD12 Facilitate Axonal Expression of GABAB Receptors in Habenula Cholinergic Neurons. J Neurosci. 2022 Mar 2;42(9):1648-1665. PMID: 35017224. PMCID: PMC8896537. DOI: 10.1523/JNEUROSCI.1676-21.2021. URL: https://www.jneurosci.org/content/42/9/1648

14. [bhandari-2021-elife-abstract] Bhandari P, Vandael D, Fernández-Fernández D, Fritzius T, Kleindienst D, Önal C, Montanaro J, Gassmann M, Jonas P, Kulik A, Bettler B, Shigemoto R, Koppensteiner P. GABAB receptor auxiliary subunits modulate Cav2.3-mediated release from medial habenula terminals. eLife. 2021 Apr 29;10:e68274. PMID: 33913808. PMCID: PMC8121548. DOI: 10.7554/eLife.68274. URL: https://elifesciences.org/articles/68274

15. [correale-2013-jmr-abstract] Correale S, Esposito C, Pirone L, Vitagliano L, Di Gaetano S, Pedone E. A biophysical characterization of the folded domains of KCTD12: insights into interaction with the GABAB2 receptor. J Mol Recognit. 2013 Oct;26(10):488-95. PMID: 23996491. DOI: 10.1002/jmr.2291. URL: https://pubmed.ncbi.nlm.nih.gov/23996491/

Citations

1. bhandari-2021-elife-abstract.md
2. booker-2017-cerebral-cortex-abstract.md
3. cathomas-2015-transl-psych-abstract.md
4. correale-2013-jmr-abstract.md
5. gassmann-2012-nrn-abstract.md
6. ivankova-2013-jbc-abstract.md
7. li-2017-prp2-abstract.md
8. metz-2011-jcn-abstract.md
9. ren-2022-jneurosci-abstract.md
10. resendes-2004-jaro-abstract.md
11. schwenk-2010-nature-abstract.md
12. schwenk-2016-nat-neurosci-abstract.md
13. teng-2019-cns-neurosci-ther-abstract.md
14. turecek-2014-neuron-abstract.md
15. zheng-2019-nature-abstract.md

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive research report: Human KCTD12 (UniProt: Q96CX2)

1) Identity, key concepts, and definitions
- Verified identity and nomenclature: KCTD12 (also known historically as Pfetin) is a human BTB/POZ- (T1-) domain-containing protein that functions as an auxiliary subunit of GABAB receptors (GBRs), shaping receptor signaling kinetics and desensitization via direct binding to the intracellular tail of GABAB2 and engagement with G-protein βγ subunits (reviewed 2024; Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008) (gonzalezhernandez2024emergingmodesof pages 5-7). Pan-cancer profiling in human tumors further frames KCTD12 in the GBR context, citing its role as an auxiliary component modulating GBR signaling and desensitization (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14).
- Domain architecture and assembly: KCTD family proteins share an N‑terminal BTB/POZ/T1 domain that mediates oligomerization and receptor binding; KCTD8/12/12b/16 directly bind the GABAB2 CTD via their T1 domains. KCTD12 operates in higher-order assemblies that are characteristically pentameric in the KCTD family; a pentameric KCTD12 complex binding the GBR is described in family-focused studies (Cells, May 2023; https://doi.org/10.3390/cells12091325; IJMS, Sep 2023; https://doi.org/10.3390/ijms241814317) (mansouri2023proteinnetworksassociated pages 8-10, liao2023kctd5formsheterooligomeric pages 9-10).

2) Mechanism, cellular localization, and pathways
- Biochemical mechanism at GABAB receptors: KCTD12 constitutively associates with the GABAB2 CTD and positions to rapidly engage Gβγ upon receptor activation, thereby accelerating activation and driving fast, Gβγ-targeted desensitization of GBR signaling. Reviews summarize that KCTD12 enhances desensitization kinetics, accelerates activation, and increases receptor surface levels (mechanisms partly unresolved) (Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008) (gonzalezhernandez2024emergingmodesof pages 5-7). Primary studies and curated analyses likewise note that KCTD12 “strongly desensitizes” GBR responses and co-purifies Gβγ even without GABAB2, consistent with direct Gβγ engagement (Cells, May 2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 8-10).
- Post-translational regulation affecting kinetics: In human cancer analyses collating GBR literature, KCTD12-dependent desensitization is reported to be modulated by phosphorylation of GABAB2 at S892 (PKA signaling), where KCTD12 binding promotes S892 phosphorylation and PKA-dependent conformational changes slow KCTD12-mediated desensitization (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9).
- Cellular and subcellular localization: In mouse cerebellum, KCTD12 localizes with mGlu1α in the same peri/post-synaptic nanodomains of Purkinje cell spines by freeze-fracture replica immunogold EM, with nearest-neighbor distances indicating close spatial association but arguing against direct physical binding (spines: 26.70 ± 2.0 nm vs mGlu1α–mGlu1α 19.73 ± 0.85 nm; two-sample KS, p = 0.0028). Co-IP from tissue pulls down KCTD12 with mGlu1α, but recombinant co-expression fails to show direct binding; the association persists in GABAB KO tissue, consistent with an indirect linkage, potentially via G-proteins or other scaffold proteins (Cells, May 2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15).
- Network and pathway context: KCTDs are BTB/T1-domain proteins with frequent pentameric assemblies and broad GPCR regulatory roles. Family-level studies in 2024 demonstrate Cullin3- and Gβ-dependent mechanisms for KCTDs (notably KCTD5) in regulating adenylyl cyclase sensitization and opioid dependence; these data underscore conserved KCTD–Gβ interactions relevant to GBR/KCTD12 signaling but are not direct KCTD12-specific findings (PLOS Biology, Jul 2024; https://doi.org/10.1371/journal.pbio.3002716) (ding2024kctdproteinsregulate pages 10-15).

3) Recent developments (2023–2024)
- GABAB–KCTD12 mechanistic updates: Authoritative review synthesis in 2024 emphasizes constitutive KCTD–GABAB2 CTD binding, Gβγ-targeted desensitization by KCTD12, and effects on activation kinetics and surface expression (Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008) (gonzalezhernandez2024emergingmodesof pages 5-7).
- Cross-receptor proximity: A 2023 cerebellar interactome and ultrastructural study identifies KCTD12 in mGlu1α-associated protein clusters and nanodomains in vivo, but indicates the interaction is indirect and independent of GABAB receptors (Cells, May 2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15, mansouri2023proteinnetworksassociated pages 8-10).
- Cancer-focused integrative analysis: Pan-cancer profiling in 2023 integrates KCTD12 biology with tumor genomics, immune infiltration, and stemness, while also consolidating GBR regulatory concepts including KCTD12-driven desensitization and S892-dependent modulation (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14).

4) Current applications and real-world implementations
- Pfetin (KCTD12) as a clinical biomarker in GIST: Pan-cancer analysis reiterates KCTD12/Pfetin as a GIST-specific biomarker with prognostic utility for recurrence based on prior clinical literature; it highlights immunohistochemistry-based detection and diagnostic potential (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9). While the integrative paper cites this application, it aggregates prior clinical studies rather than providing new prospective validation.
- Broader oncology utility: The same study suggests diagnostic sensitivity across tumor types and correlations with tumor microenvironment features, implying potential for risk stratification or companion biomarker roles pending disease- and context-specific validation (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14).

5) Expert opinions and authoritative commentary
- A 2024 Trends in Neurosciences review frames KCTD12 as a prototypical GBR auxiliary subunit that binds GABAB2 CTD and targets Gβγ to confer rapid desensitization, with added effects on activation and receptor trafficking; it emphasizes that mechanisms for surface level increases remain incompletely defined (Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008) (gonzalezhernandez2024emergingmodesof pages 5-7).
- Family-level insights: Contemporary work on KCTDs and Cullin3-centric complexes (though focused on other KCTDs) underscore BTB/T1-driven assemblies and Gβ-centric signaling control as a common architectural theme, aligning with KCTD12’s GBR functions (PLOS Biology, Jul 2024; https://doi.org/10.1371/journal.pbio.3002716) (ding2024kctdproteinsregulate pages 10-15).

6) Quantitative data and statistics from recent studies
- mGlu1–KCTD12 nanoscale organization in cerebellar Purkinje cells: nearest-neighbor analysis showed mGlu1α–KCTD12 mean distances 26.70 ± 2.0 nm (spines) and 36.86 ± 3.44 nm (dendrites), significantly larger than mGlu1α–mGlu1α distances (19.73 ± 0.85 nm; 22.90 ± 0.95 nm), arguing against direct binding (KS tests spines p = 0.0028; dendrites p = 0.0001) (Cells, May 2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15).
- Pan-cancer transcriptome and proteome statistics: KCTD12 co-expression included CSF1R (R = 0.64, P < 0.001) and DCHS1 (R = 0.53, P < 0.001); stemness correlations example values: THYM R = 0.3638 (P = 4.75E-05), GBM R = -0.5566 (P = 2.22E-05), TGCT R = -0.6045 (P = 5.19E-16), BLCA R = -0.3408 (P = 2.05E-12). Immune infiltration correlations with CAFs and T cells were evaluated across multiple algorithms (EPIC, MCP-COUNTER, XCELL, TIDE); the study details significant associations in specific cancers (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14).

7) Clarifications on Cullin3/E3 ligase questions for KCTD12
- While multiple KCTD proteins recruit Cullin3 via BTB domains to form CRL3 E3 ligases, direct Cul3 engagement is strongly supported for certain family members (e.g., KCTD5), with family-level opioid signaling work showing KCTD–Gβ interactions and Cul3 dependence. The 2023–2024 evidence compiled here does not provide direct biochemical proof that KCTD12 forms a functional CRL3 with Cul3; by contrast, KCTD12’s best-established role remains its GBR auxiliary subunit function via GABAB2 CTD and Gβγ interactions (PLOS Biology, Jul 2024; https://doi.org/10.1371/journal.pbio.3002716; Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008; Cells, May 2023; https://doi.org/10.3390/cells12091325) (ding2024kctdproteinsregulate pages 10-15, gonzalezhernandez2024emergingmodesof pages 5-7, mansouri2023proteinnetworksassociated pages 8-10).

8) Synthesis and functional annotation
- Primary function: KCTD12 is a non-enzymatic scaffold/auxiliary subunit that directly binds the GABAB2 C-terminus and Gβγ to sculpt GBR signaling—accelerating activation, promoting rapid Gβγ-targeted desensitization, and influencing receptor surface expression (Trends in Neurosciences, Aug 2024; https://doi.org/10.1016/j.tins.2024.05.008; Cells, May 2023; https://doi.org/10.3390/cells12091325) (gonzalezhernandez2024emergingmodesof pages 5-7, mansouri2023proteinnetworksassociated pages 8-10).
- Site of action: Predominantly at neuronal synapses where GABAB receptors operate; in the cerebellum, KCTD12 resides in postsynaptic nanodomains of Purkinje cell spines and dendrites, and can be found in mGlu1α-containing clusters via indirect associations (Cells, May 2023; https://doi.org/10.3390/cells12091325) (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15).
- Broader relevance: Systems-level analyses tie KCTD12 expression to tumor biology and immune/stemness features; clinically, KCTD12/Pfetin has been repeatedly reported as a GIST prognostic biomarker (Scientific Reports, Aug 2023; https://doi.org/10.1038/s41598-023-41091-8) (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14).

Limitations of current evidence in this synthesis
- Direct human structural data for KCTD12 pentamers and Cul3 recruitment are not included in the cited 2023–2024 sources compiled here; pentameric assembly is supported by family-level literature and specific statements referencing KCTD12 complexes (IJMS, Sep 2023; https://doi.org/10.3390/ijms241814317) (liao2023kctd5formsheterooligomeric pages 9-10). The cerebellar mGlu1α association appears indirect and requires further molecular dissection (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15).

References (with URLs and dates)
- Gonzalez-Hernandez AJ, Munguba H, Levitz J. Emerging modes of regulation of neuromodulatory G protein-coupled receptors. Trends in Neurosciences. Aug 2024. https://doi.org/10.1016/j.tins.2024.05.008 (gonzalezhernandez2024emergingmodesof pages 5-7)
- Mansouri M et al. Protein Networks Associated with Native Metabotropic Glutamate 1 Receptors (mGlu1) in the Mouse Cerebellum. Cells. May 2023. https://doi.org/10.3390/cells12091325 (mansouri2023proteinnetworksassociated pages 10-13, mansouri2023proteinnetworksassociated pages 13-15, mansouri2023proteinnetworksassociated pages 8-10)
- Liu P et al. A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer. Scientific Reports. Aug 2023. https://doi.org/10.1038/s41598-023-41091-8 (liu2023apancanceranalysis pages 6-9, liu2023apancanceranalysis pages 13-14)
- Liao Y et al. KCTD5 Forms Hetero-Oligomeric Complexes with Various Members of the KCTD Protein Family. International Journal of Molecular Sciences. Sep 2023. https://doi.org/10.3390/ijms241814317 (liao2023kctd5formsheterooligomeric pages 9-10)
- Ding Z et al. KCTD proteins regulate morphine dependence via heterologous sensitization of adenylyl cyclase 1 in mice. PLOS Biology. Jul 2024. https://doi.org/10.1371/journal.pbio.3002716 (ding2024kctdproteinsregulate pages 10-15)

References

1. (gonzalezhernandez2024emergingmodesof pages 5-7): Alberto J. Gonzalez-Hernandez, Hermany Munguba, and Joshua Levitz. Emerging modes of regulation of neuromodulatory g protein-coupled receptors. Trends in Neurosciences, 47:635-650, Aug 2024. URL: https://doi.org/10.1016/j.tins.2024.05.008, doi:10.1016/j.tins.2024.05.008. This article has 23 citations and is from a highest quality peer-reviewed journal.

2. (liu2023apancanceranalysis pages 6-9): Pan Liu, Zhilan Liu, Qiankun Luo, Qiang Fu, Xu Zhang, Pengfei Yu, Shuai Zhou, Yingying Wang, Jiali Zhang, Song Chen, Hongwei Zhang, Qinghai Zhu, and Tao Qin. A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer. Scientific Reports, Aug 2023. URL: https://doi.org/10.1038/s41598-023-41091-8, doi:10.1038/s41598-023-41091-8. This article has 6 citations and is from a peer-reviewed journal.

3. (liu2023apancanceranalysis pages 13-14): Pan Liu, Zhilan Liu, Qiankun Luo, Qiang Fu, Xu Zhang, Pengfei Yu, Shuai Zhou, Yingying Wang, Jiali Zhang, Song Chen, Hongwei Zhang, Qinghai Zhu, and Tao Qin. A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer. Scientific Reports, Aug 2023. URL: https://doi.org/10.1038/s41598-023-41091-8, doi:10.1038/s41598-023-41091-8. This article has 6 citations and is from a peer-reviewed journal.

4. (mansouri2023proteinnetworksassociated pages 8-10): Mahnaz Mansouri, Leopold Kremser, Thanh-Phuong Nguyen, Yu Kasugai, Laura Caberlotto, Martin Gassmann, Bettina Sarg, Herbert Lindner, Bernhard Bettler, Lucia Carboni, and Francesco Ferraguti. Protein networks associated with native metabotropic glutamate 1 receptors (mglu1) in the mouse cerebellum. Cells, 12:1325, May 2023. URL: https://doi.org/10.3390/cells12091325, doi:10.3390/cells12091325. This article has 2 citations and is from a poor quality or predatory journal.

5. (liao2023kctd5formsheterooligomeric pages 9-10): Yini Liao, Douglas C. Sloan, Josephine H. Widjaja, and Brian S. Muntean. Kctd5 forms hetero-oligomeric complexes with various members of the kctd protein family. International Journal of Molecular Sciences, 24:14317, Sep 2023. URL: https://doi.org/10.3390/ijms241814317, doi:10.3390/ijms241814317. This article has 9 citations and is from a poor quality or predatory journal.

6. (mansouri2023proteinnetworksassociated pages 10-13): Mahnaz Mansouri, Leopold Kremser, Thanh-Phuong Nguyen, Yu Kasugai, Laura Caberlotto, Martin Gassmann, Bettina Sarg, Herbert Lindner, Bernhard Bettler, Lucia Carboni, and Francesco Ferraguti. Protein networks associated with native metabotropic glutamate 1 receptors (mglu1) in the mouse cerebellum. Cells, 12:1325, May 2023. URL: https://doi.org/10.3390/cells12091325, doi:10.3390/cells12091325. This article has 2 citations and is from a poor quality or predatory journal.

7. (mansouri2023proteinnetworksassociated pages 13-15): Mahnaz Mansouri, Leopold Kremser, Thanh-Phuong Nguyen, Yu Kasugai, Laura Caberlotto, Martin Gassmann, Bettina Sarg, Herbert Lindner, Bernhard Bettler, Lucia Carboni, and Francesco Ferraguti. Protein networks associated with native metabotropic glutamate 1 receptors (mglu1) in the mouse cerebellum. Cells, 12:1325, May 2023. URL: https://doi.org/10.3390/cells12091325, doi:10.3390/cells12091325. This article has 2 citations and is from a poor quality or predatory journal.

8. (ding2024kctdproteinsregulate pages 10-15): Zhong Ding, Chunsheng Zhang, Huicui Yang, Jiaojiao Chen, Zhiruo Sun, and Xuechu Zhen. Kctd proteins regulate morphine dependence via heterologous sensitization of adenylyl cyclase 1 in mice. PLOS Biology, 22:e3002716, Jul 2024. URL: https://doi.org/10.1371/journal.pbio.3002716, doi:10.1371/journal.pbio.3002716. This article has 3 citations and is from a highest quality peer-reviewed journal.

Citations

1. gonzalezhernandez2024emergingmodesof pages 5-7
2. mansouri2023proteinnetworksassociated pages 8-10
3. liu2023apancanceranalysis pages 6-9
4. ding2024kctdproteinsregulate pages 10-15
5. liu2023apancanceranalysis pages 13-14
6. mansouri2023proteinnetworksassociated pages 10-13
7. mansouri2023proteinnetworksassociated pages 13-15
8. https://doi.org/10.1016/j.tins.2024.05.008
9. https://doi.org/10.1038/s41598-023-41091-8
10. https://doi.org/10.3390/cells12091325;
11. https://doi.org/10.3390/ijms241814317
12. https://doi.org/10.3390/cells12091325
13. https://doi.org/10.1371/journal.pbio.3002716
14. https://doi.org/10.1371/journal.pbio.3002716;
15. https://doi.org/10.1016/j.tins.2024.05.008;
16. https://doi.org/10.1016/j.tins.2024.05.008,
17. https://doi.org/10.1038/s41598-023-41091-8,
18. https://doi.org/10.3390/cells12091325,
19. https://doi.org/10.3390/ijms241814317,
20. https://doi.org/10.1371/journal.pbio.3002716,

KCTD12 (BTB/POZ Domain-Containing Protein KCTD12) – Functional Annotation and Recent Insights

Gene Identity and Structure

KCTD12 is a human gene (Homo sapiens) encoding the BTB/POZ domain-containing protein KCTD12, also known as Pfetin (Predominantly Fetal Expressed T1 domain protein) (biosignaling.biomedcentral.com). The gene is located on chromosome 13 (13q22.3) and was originally identified as C13orf2/KIAA1778 in genomic surveys. KCTD12 belongs to the KCTD family (Potassium Channel Tetramerization Domain-containing proteins), a group of 25 proteins characterized by a conserved N-terminal BTB/POZ domain (biosignaling.biomedcentral.com). The BTB/POZ domain (≈95 amino acids) mediates protein–protein interactions and oligomerization (biosignaling.biomedcentral.com). Indeed, KCTD12 self-assembles into a homotetramer via this BTB domain (journals.plos.org), similar to the tetramerization domain of voltage-gated K⁺ channels (hence the family name). KCTD12’s C-terminal region (sometimes called the “H1 domain”) is a unique segment that confers its specific interactions and functions (www.nature.com). Notably, KCTD12 lacks any transmembrane region and is predominantly a cytosolic protein. It tends to localize to the cytosolic face of cellular membranes by binding to membrane-bound partners, as described below. This gene is expressed highly in the nervous system, especially in the brain (www.sciencedirect.com) (biosignaling.biomedcentral.com), and was first noted for its strong expression in fetal tissues (hence the name Pfetin) (biosignaling.biomedcentral.com). In adult tissues, KCTD12 expression is largely neuronal; outside the brain it is low or absent under normal conditions (www.sciencedirect.com).

Verification of Identity: The KCTD12 described here corresponds to UniProt accession Q96CX2, a human protein with a BTB/POZ domain, and not to any unrelated gene. The protein’s synonyms (Pfetin, C13orf2, PFET1) and domain composition match the UniProt record, ensuring we are focusing on the correct gene product. KCTD12 should not be confused with similarly named genes in other species or with other KCTD family members. All information below refers to human KCTD12 as identified above.

Role as an Auxiliary Subunit of GABA_B Receptors (Neuronal Function)

KCTD12 is best known for its role in the nervous system as an auxiliary subunit of the GABA_B receptor, a G-protein-coupled receptor (GPCR) for the neurotransmitter γ-aminobutyric acid (GABA). In 2010, native GABA_B receptors were discovered to form heteromultimeric complexes with KCTD family proteins, including KCTD12 (journals.plos.org). KCTD12, along with its paralogs KCTD8 and KCTD16, comprises the “Clade F” of KCTDs dedicated to GABA_B modulation (biosignaling.biomedcentral.com). These cytosolic proteins attach to the C-terminal intracellular domain of the GABA_B2 subunit, becoming integral components of the receptor complex (journals.plos.org). KCTD12 association does not alter receptor assembly or trafficking to the surface, as KCTD12 binds the receptor already in the endoplasmic reticulum without impeding normal maturation (pubmed.ncbi.nlm.nih.gov). In fact, KCTD12 remains bound to GABA_B receptors at the cell surface and during endocytosis (pubmed.ncbi.nlm.nih.gov). This stable association has important functional consequences for GABA_B signaling.

Upregulation of Receptor Signaling: KCTD12 increases the availability and efficacy of GABA_B receptors on the neuronal surface. Experiments in heterologous cells and neurons show that assembling KCTD12 with GABA_B receptors in the ER leads to reduced constitutive receptor internalization (pubmed.ncbi.nlm.nih.gov). In other words, KCTD12 acts as a retention factor, keeping more receptors at the plasma membrane. As a result, neurons with KCTD12 have a higher magnitude of GABA_{B>-mediated currents. Notably, knocking out or silencing Kctd12 in mouse hippocampal neurons significantly reduces the GABAB-activated K⁺ current (mediated by G-protein gated inward rectifier K⁺ channels), indicating that KCTD12 normally enhances the functional coupling of receptors to ion channel signaling (pubmed.ncbi.nlm.nih.gov). Consistently, a 2013 biochemical study demonstrated that KCTD12 up-regulates GABAB receptor signaling by increasing receptor density at the membrane and stabilizing receptor–G protein interactions (pubmed.ncbi.nlm.nih.gov).}

Effects on Pharmacology and Kinetics: Beyond boosting signal amplitude, KCTD12 profoundly shapes the kinetic profile and pharmacological properties of GABA_B receptor responses. KCTD12-bound receptors exhibit altered agonist potency and faster onset and desensitization of inhibitory currents compared to receptors without KCTD subunits (pubmed.ncbi.nlm.nih.gov) (www.sciencedirect.com). In electrophysiological recordings, the presence of KCTD12 causes the GABA_{B>-activated K⁺ current to desensitize rapidly and more profoundly during sustained agonist exposure (journals.plos.org). Mechanistically, KCTD12’s C-terminal “H1” domain directly interacts with the G-protein βγ subunits released upon receptor activation (www.nature.com) (www.nature.com). Structural studies (Nature, 2019) revealed that the H1 domain of KCTD12 binds Gβγ at a specific interface, sequestering the Gβγ complex away from its effector (the potassium channel) (www.nature.com) (www.nature.com). This creates a brake on GABAB> signaling, producing rapid desensitization of the inhibitory downstream effect (the K⁺ current) (journals.plos.org). A critical motif (NFLEQ) in KCTD12’s H1 domain is required for this desensitizing effect (www.nature.com), highlighting how a specific sequence in KCTD12 modulates receptor signaling kinetics. Furthermore, KCTD12 was shown to influence agonist pharmacodynamics: for instance, incorporation of KCTD12 can shift the EC50 for GABA, effectively altering the receptor’s sensitivity to neurotransmitter (pubmed.ncbi.nlm.nih.gov). In summary, KCTD12 acts as a modulatory subunit that fine-tunes GABAB receptor function, increasing the magnitude of signaling while accelerating its kinetics. This dual action shapes synaptic inhibition in the brain, ensuring a strong but transient response to GABA.}

Biological Significance in the Brain: The GABA_B receptor is a principal mediator of slow inhibitory synaptic transmission in the central nervous system. By associating with these receptors, KCTD12 plays a role in regulating neuronal excitability, synaptic plasticity, and behavior. Variations in KCTD12 function have been linked to neurological and psychiatric phenomena. For example, genetic studies have implicated KCTD12 variants in mood and cognitive disorders. A genome-wide association analysis in 2019 found KCTD12 to be significantly associated with the trait of rumination, a risk factor for depression (www.nature.com). Other research has noted KCTD12 as a candidate gene in bipolar disorder and schizophrenia cohorts (www.nature.com). In mouse models, Kctd12 expression in the hippocampus was induced by chronic stress, and experimentally elevating Kctd12 made mice more vulnerable to depressive-like behaviors, whereas Kctd12 knockdown had a resilience effect (www.sciencedirect.com) (www.sciencedirect.com). These findings suggest that KCTD12’s regulation of GABA_B signaling can impact stress responses and mood, aligning with the protein’s role in inhibitory neurotransmission. It is being explored as a potential therapeutic target in stress-related mood disorders (www.sciencedirect.com). Overall, in the nervous system KCTD12 functions as an adapter protein in a key inhibitory pathway, helping to maintain the balance of neural activity through its modulation of GABA_B receptors.

Mechanistic Properties and Interactions

Structural Assembly: KCTD12’s BTB domain mediates both homo-oligomerization and interaction with partner proteins. As noted, KCTD12 assembles into a tetramer (dimer-of-dimers) via the BTB domain (journals.plos.org). This tetramer is the functional unit that attaches to a GABA_B receptor: biochemical pull-downs have shown one KCTD12 tetramer can bind the dimeric GABA_B1-GABA_B2 receptor complex (www.nature.com). The BTB domain of KCTD12 specifically binds to a segment of the GABA_B2 intracellular tail, tethering the KCTD12 tetramer to the receptor (www.nature.com). Meanwhile, the flexible C-terminal region of KCTD12 reaches to interact with G-proteins as described. This multivalent bridging role is unique for KCTD12’s clade. It’s worth noting that many BTB-domain proteins serve as adapters for Cullin3-based ubiquitin ligase complexes (CRL3). However, KCTD12 does not seem to function in ubiquitin-mediated proteolysis. Biophysical studies have found that the isolated BTB domain of KCTD12 fails to bind the Cullin3 scaffold, in contrast to certain other KCTDs (journals.plos.org) (journals.plos.org). Isothermal titration calorimetry and gel filtration assays showed no stable interaction between KCTD12’s BTB domain and Cullin3, whereas BTBs from KCTD11 or KCTD6 (related family members) form robust Cul3 complexes (journals.plos.org) (journals.plos.org). This indicates that KCTD12’s functions are “Cullin-independent”, aligning with its role in receptor signaling rather than serving as an E3 ubiquitin ligase adapter. Instead of targeting proteins for degradation, KCTD12’s BTB/POZ domain primarily mediates assembly with the GABA_B receptor complex and possibly other protein partners in non-neuronal contexts.

Signaling Pathways: Through its protein–protein interactions, KCTD12 can influence several cellular signaling pathways. In neurons, the key pathway is G_i/o-protein signaling downstream of GABA_B. By binding Gβγ, KCTD12 effectively regulates the Gβγ–effector pathway (which includes activation of inward-rectifier K⁺ channels and inhibition of adenylyl cyclase). This has ripple effects on ion channel activity and second-messenger (cAMP) levels in neurons (pmc.ncbi.nlm.nih.gov). Importantly, sequestration of Gβγ by KCTD12 also means less Gβγ is available to activate intracellular enzymes like PI3K. In fact, KCTD12 has been noted to dampen PI3K–AKT signaling in some contexts (biosignaling.biomedcentral.com). Gβγ normally activates class I PI3K, leading to AKT phosphorylation. A 2021 review pointed out that KCTD12 can inhibit AKT pathway activation, presumably by interfering with Gβγ’s ability to stimulate PI3K (biosignaling.biomedcentral.com). This mechanism is analogous to KCTD5 (another family member) which promotes ubiquitin-mediated turnover of Gβγ, thereby reducing AKT signaling (biosignaling.biomedcentral.com). While KCTD12 does not ubiquitinate Gβγ, its direct binding might spatially sequester Gβγ or otherwise impede prolonged PI3K activation. Thus, through GABA_B or other G-protein-coupled mechanisms, KCTD12 may exert a braking effect on the PI3K/AKT pathway. In support of this, loss of KCTD12 has been correlated with increased AKT activity in certain cell types. For example, in breast cancer cells, silencing KCTD12 led to enhanced AKT phosphorylation and accelerated cell cycle progression, while restoring KCTD12 curbed AKT signaling and proliferation (biosignaling.biomedcentral.com) (biosignaling.biomedcentral.com).

Outside of neuronal signaling, emerging evidence suggests KCTD12 can interact with components of the cell cycle regulatory machinery. Notably, in some cancer cell contexts KCTD12 was found to bind CDK1 (cyclin-dependent kinase 1) and CDC25B, forming a complex that facilitates CDK1 activation and entry into mitosis (biosignaling.biomedcentral.com). A study reported that high KCTD12 levels can promote the G2/M cell cycle transition by supporting the CDK1/CDC25B/Aurora A kinase axis (biosignaling.biomedcentral.com). In these cells, KCTD12 acted unconventionally as a pro-proliferative factor: disrupting the KCTD12–CDK1 interaction using small molecules or siRNA was shown to suppress tumor cell growth (biosignaling.biomedcentral.com). This finding is intriguing because it positions KCTD12 in a completely different pathway (cell cycle control) separate from its GABA_B role. It hints that KCTD12’s protein–protein interaction capacity (via the BTB domain or other regions) might allow it to serve as a scaffold or regulator in various signaling complexes depending on the cell type. However, such interactions are context-dependent and may not occur in all tissues.

In summary, KCTD12 is a versatile adaptor protein. In neurons it couples a neurotransmitter receptor to ion channels and G-proteins, modulating synaptic inhibition. In other cells, it can interface with signaling pathways like MAPK/ERK and cell-cycle kinases (as discussed below in disease contexts). Unlike many KCTDs, it does not broadly function in ubiquitin ligation, but it can still influence protein stability indirectly by affecting signaling cascades (e.g., reducing GABA_{B> receptor internalization, or impacting Gβγ stability via KCTD5 partnership). The precise mechanisms of KCTD12 in non-neuronal cells remain an active area of research.}

Involvement in Biological Processes and Disease Contexts

KCTD12 in Cancer and Cell Proliferation

Although KCTD12 is largely a neuronal protein, it has attracted significant interest in oncology due to its aberrant expression in tumors and potential role in tumor cell biology. KCTD12 was first spotlighted in cancer research under the name Pfetin in gastrointestinal stromal tumors. In a landmark proteomics study, pfetin (KCTD12) was identified as a protein strongly expressed in tumors with favorable outcomes (biosignaling.biomedcentral.com) (biosignaling.biomedcentral.com). Subsequent analysis of patient samples revealed pfetin as a prognostic biomarker in GIST (Gastrointestinal Stromal Tumors) (biosignaling.biomedcentral.com). Patients whose GIST tumors retained KCTD12 expression had markedly better survival than those whose tumors lost KCTD12. One study reported a 5-year recurrence-free survival of 95.6% in KCTD12-positive GISTs vs. only 16.7% in KCTD12-negative cases (p < 0.0001) (www.sciencedirect.com). In multivariate analysis, KCTD12 status was an independent predictor of patient outcome, even when accounting for other factors like proliferative index (www.sciencedirect.com). These data firmly established KCTD12 as a useful clinical biomarker for GIST diagnosis and prognosis (www.sciencedirect.com). Immunohistochemical testing for pfetin has been suggested to help identify low-risk GIST patients, as loss of KCTD12 correlates with aggressive, high-risk disease (biosignaling.biomedcentral.com).

The tumor-suppressive association of KCTD12 is not limited to GIST. Downregulation or loss of KCTD12 has been observed in multiple cancers, often correlating with increased malignancy:

• Colorectal Cancer (CRC): KCTD12 levels are significantly reduced in colorectal carcinoma tissues compared to normal colon epithelium (www.nature.com). Low KCTD12 in CRC is linked to tumor progression; it was found to be an independent prognostic factor for poorer overall and disease-free survival in patients (p = 0.007) (www.nature.com). Functionally, KCTD12 appears to restrain the stem-like properties of CRC cells. A 2016 study showed that silencing KCTD12 enhanced cancer stem cell markers and self-renewal in CRC cells, whereas overexpressing KCTD12 suppressed these stemness traits (www.nature.com). Mechanistically, KCTD12 suppresses the ERK/MAPK pathway in CRC cells – loss of KCTD12 led to hyperactivation of ERK1/2 and upregulation of stemness genes, while an ERK inhibitor could reverse the effects of KCTD12 knockdown (www.nature.com). This places KCTD12 as a negative regulator of the pro-proliferative ERK pathway. Consistently, KCTD12-deficient CRC xenograft tumors grew more aggressively in mice, whereas KCTD12 restoration reduced tumor growth and metastasis (biosignaling.biomedcentral.com) (biosignaling.biomedcentral.com). These findings suggest KCTD12 acts as a tumor suppressor in colorectal cancer, keeping oncogenic pathways like ERK in check and limiting the stem cell–like subpopulation of tumor cells.

• Breast Cancer: Large-scale transcriptomic analyses (e.g. TCGA data mining in 2021) found that KCTD12 expression is frequently downregulated in breast cancer tissue compared to normal breast (biosignaling.biomedcentral.com). Low KCTD12 in breast tumors was associated with more aggressive clinicopathological features and worse patient survival (biosignaling.biomedcentral.com). Functional studies demonstrated that knocking down KCTD12 in breast cancer cell lines accelerates proliferation and drives cells from G1 into S phase (biosignaling.biomedcentral.com). This was linked to hyperactivation of the AKT pathway when KCTD12 is absent: AKT phosphorylation increased, leading to downstream effects on cell cycle regulators (such as FOXO1) (biosignaling.biomedcentral.com). Conversely, reintroducing or overexpressing KCTD12 in these cells dampened AKT signaling and slowed cell cycle progression (biosignaling.biomedcentral.com). Therefore, in breast cancer KCTD12 seems to inhibit growth by modulating PI3K–AKT signaling and cell cycle checkpoints. Clinically, one 2021 study identified KCTD12 as a potential prognostic marker in breast cancer, noting that higher KCTD12 correlates with better survival and possibly a more robust anti-tumor immune response (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Gene set enrichment hinted that KCTD12 might influence the tumor microenvironment and immune cell infiltration in breast tumors (pmc.ncbi.nlm.nih.gov), although the exact mechanisms are still being unraveled.

• Melanoma: KCTD12 has also been reported to act as a tumor suppressor in melanoma. Metastatic melanoma cell lines showed lower KCTD12 levels compared to their primary tumor counterparts (tcr.amegroups.org). Experimental downregulation of KCTD12 in melanoma was found to increase the expression of stemness markers and enhance the aggressive behavior of melanoma cells (tcr.amegroups.org). Conversely, enforcing KCTD12 expression in melanoma cells induces cell cycle arrest in G2/M, slows proliferation, and promotes apoptosis (biosignaling.biomedcentral.com). In an in vivo melanoma xenograft model, tumors with high KCTD12 grew more slowly, supporting its growth-inhibitory role (biosignaling.biomedcentral.com). These effects in melanoma were tied to KCTD12’s interference with cell cycle regulators, echoing the pattern seen in other cancers.

• Esophageal Squamous Cell Carcinoma (ESCC): Similarly, KCTD12 appears to function as a tumor suppressor in ESCC. A 2018 study noted that KCTD12 is frequently silenced in ESCC tumors, and its loss correlates with advanced disease (biosignaling.biomedcentral.com). Restoration of KCTD12 in ESCC cell lines inhibited their growth, suggesting therapeutic potential (biosignaling.biomedcentral.com).

Intriguingly, not all cancers follow the same pattern. There are reports where KCTD12 is upregulated and may contribute to oncogenesis in certain contexts:

• In cervical carcinoma, lung adenocarcinoma, and a subset of colon cancers, tumor samples have shown higher-than-normal KCTD12 expression, and this was paradoxically associated with poorer patient prognosis (biosignaling.biomedcentral.com) (biosignaling.biomedcentral.com). In these cases, KCTD12 might be co-opted by cancer cells to drive proliferation. The mechanism proposed involves the KCTD12–CDK1 interaction mentioned earlier: high KCTD12 can bind and support CDK1/cyclin activity, thus promoting the G2/M transition and rapid cell division (biosignaling.biomedcentral.com). For example, an Oncogene study in 2017 demonstrated that KCTD12 binds the mitotic kinase CDC25B and stabilizes the CDC25B–CDK1–Aurora A complex, facilitating mitotic entry and tumor growth (biosignaling.biomedcentral.com). Inhibiting KCTD12 (genetically or with drugs) in those cancer cells disrupted this complex and suppressed tumor cell proliferation (biosignaling.biomedcentral.com). Therefore, in some malignancies KCTD12 may act as a context-dependent oncogene, especially when its interplay with cell cycle regulators becomes advantageous to the tumor. It is possible that the role of KCTD12 in cancer is cell-type specific, influenced by which signaling pathways are dominant in that cancer. The dual nature of KCTD12 – tumor-suppressive in some settings and tumor-promoting in others – underscores the complexity of cancer biology. It may reflect different interaction partners or post-translational modifications of KCTD12 in different cellular environments (biosignaling.biomedcentral.com) (biosignaling.biomedcentral.com). Current research is investigating what factors dictate these opposite roles.

Current Applications and Clinical Relevance

Given these findings, KCTD12 is being explored in several practical contexts:

• Biomarker Development: KCTD12/Pfetin is already used as a biomarker in GIST pathology. Some clinical centers have incorporated pfetin immunohistochemistry to help stratify GIST patients by risk of recurrence (biosignaling.biomedcentral.com). Its remarkable prognostic power (nearly 80% difference in 5-year recurrence-free survival based on expression) makes it a valuable adjunct to traditional risk factors (www.sciencedirect.com). Researchers have suggested using KCTD12 in combination with markers like Ki-67 to improve GIST outcome predictions (www.sciencedirect.com). Additionally, pan-cancer analyses in 2023 have highlighted KCTD12 as a potential diagnostic marker across multiple tumor types (www.nature.com) (www.nature.com). In a comprehensive study of >30 cancers (using TCGA data), KCTD12 levels were found to be significantly different in tumors vs. normal tissue for several cancers (www.nature.com). For example, KCTD12 mRNA/protein was generally down in malignancies such as colorectal, uterine, and head/neck cancers (consistent with tumor-suppressor behavior), while elevated in a few others like pancreatic adenocarcinoma and glioblastoma (www.nature.com). That study also showed KCTD12 expression had high diagnostic sensitivity for certain cancers and correlated with features like tumor mutational burden and immune infiltration (www.nature.com). Such findings pave the way for using KCTD12 as part of multi-gene panels for cancer diagnosis or prognostication.

• Therapeutic Target Research: KCTD12’s role in GABA_B signaling makes it a potential target in neurological disorders. While no drugs currently target KCTD12 directly, understanding its modulation of GABA_B could inform treatments for epilepsy, pain, or depression (where GABA_B receptors are relevant). For instance, if KCTD12 upregulation contributes to stress susceptibility (www.sciencedirect.com) (www.sciencedirect.com), then disrupting KCTD12–GABA_B interactions might have antidepressant or anxiolytic effects. Conversely, enhancing KCTD12 function could potentially strengthen inhibitory signaling in conditions of hyperexcitability. These ideas are still speculative, but KCTD12-knockout mice and other models are being studied to evaluate behavioral and cognitive impacts (www.sciencedirect.com). In oncology, KCTD12 is not yet a direct drug target, but its involvement in pathways like ERK, AKT, and cell cycle makes it an attractive node for intervention. For tumors where KCTD12 is lost, strategies to boost its expression or mimic its effect (e.g. dampening ERK/AKT signaling) could be beneficial. Conversely, in tumors that seem to exploit KCTD12 for proliferation, disrupting the KCTD12–CDK1 interaction is a novel angle for therapy (biosignaling.biomedcentral.com). A 2020 study showed that an existing drug (adefovir dipivoxil) unexpectedly could disrupt the KCTD12–CDK1 complex, sensitizing colon cancer cells to a BRAF inhibitor (biosignaling.biomedcentral.com). This suggests that repurposing drugs to modulate KCTD12’s protein interactions might have therapeutic merit in certain cancers. All of these applications are in early research stages, with ongoing studies to validate KCTD12 as a safe and effective target.

• Research Tool and Pathway Marker: KCTD12 is also used in research as a marker of certain cell states. For example, in neuroscience, it serves as a marker of mature inhibitory synapses due to its enrichment in neuronal tissue. In cancer biology, changes in KCTD12 are sometimes measured to indicate a shift towards a stem-like state or EMT (epithelial–mesenchymal transition) in tumors (www.nature.com) (biosignaling.biomedcentral.com). As a member of the Cullin3-independent BTB proteins, KCTD12 is studied to better understand the structural basis of BTB domain specificity. Crystallographic analyses of KCTD12 domains (including PDB structures of KCTD12 H1 in complex with Gβγ) provide a template for designing molecules that can modulate its function (www.nature.com) (www.nature.com).

Recent Developments and Expert Perspectives (2023–2024)

Research on KCTD12 is very active, with recent studies expanding our understanding of its roles. In 2023, a pan-cancer analysis (Scientific Reports, Sept 2023) provided a comprehensive update on KCTD12 in oncology (www.nature.com). This analysis reinforced that abnormal KCTD12 expression is widespread across cancers and often correlates with clinical outcomes (www.nature.com) (www.nature.com). Specifically, the study found that KCTD12 downregulation in tumors like colorectal, uterine, and liver cancer is associated with worse survival, supporting the tumor-suppressor view. It also highlighted KCTD12’s relationship with the tumor immune microenvironment: for instance, in several cancers (cervical, head/neck, pancreatic), higher KCTD12 correlated with greater infiltration of CD8⁺ T cells and fibroblasts, suggesting KCTD12 might influence or reflect immune activation in tumors (www.nature.com) (www.nature.com). Such insights are prompting new questions about whether KCTD12 has immunomodulatory functions in cancer or if it’s simply a marker of a less aggressive, more immune-accessible tumor phenotype.

Authoritative reviews have also synthesized knowledge on KCTD12. A 2021 review in Cell Communication and Signaling noted that “KCTD12 has been linked to tumorigenesis, in some contexts as a potential oncosuppressor, in other contexts as an oncogene.” (biosignaling.biomedcentral.com). This reflects the consensus that KCTD12’s function is context-dependent. The same review emphasizes KCTD12’s origin as a fetal gene and its prominence in neurological function (GABA_B modulation) alongside its emerging cancer roles (biosignaling.biomedcentral.com) (biosignaling.biomedcentral.com). Experts stress examining the molecular interactions of KCTD12 to explain these divergent roles. For example, Dr. Enrico De Smaele and colleagues (2021) propose that when KCTD12 is part of a Cullin3 ubiquitin pathway (even if binding is weak, perhaps via hetero-oligomerization with other KCTDs), it might affect protein degradation processes, whereas in neurons it clearly works in a Cullin-independent manner (biosignaling.biomedcentral.com) (journals.plos.org). Understanding these nuances is key to leveraging KCTD12 in medicine.

In the neuroscience field, recent structural work has provided near-atomic detail of KCTD12. Cryo-EM and crystallography studies by Maestro et al. (2019) elucidated how KCTD12’s H1 domain latches onto Gβγ and how the BTB tetramer connects to GABA_B2 (www.nature.com) (www.nature.com). These structural insights confirm earlier functional data and suggest ways to modulate KCTD12’s effect. For instance, mutants of KCTD12 that disrupt Gβγ binding (e.g. an H1 domain mutant of conserved arginine residues) fail to localize properly or induce desensitization (www.nature.com). Such findings could inform the design of small molecules that disrupt KCTD12–Gβγ interactions as a means to tweak GABA_B signaling. As of 2024, no drugs target KCTD12 specifically, but the concept of “auxiliary subunit pharmacology” is gaining traction – i.e., targeting receptor complexes via their accessory subunits.

Another recent development is the exploration of KCTD12 in psychiatric genetics. Building on earlier GWAS signals, studies in 2022–2023 have examined KCTD12’s brain expression and regulatory variants. While findings are still preliminary, KCTD12 is increasingly recognized as a gene of interest in neuropsychiatric conditions such as schizophrenia, autism, and mood disorders. Its role in modulating inhibitory neurotransmission makes it a plausible contributor to neural circuit dysfunctions underlying these illnesses.

Finally, the research community is investigating KCTD12 isoforms and homologs. There is a splice variant sometimes called KCTD12b (originally identified in certain species), which shares similarity with KCTD12. Studies are determining if KCTD12b in humans has distinct functions or tissue distribution. Additionally, cross-species comparisons (e.g., examining KCTD12 in model organisms like Drosophila or C. elegans, which have related BTB proteins) are used to infer evolutionarily conserved functions. The fact that KCTD12 is conserved in vertebrates and highly expressed in the brain suggests it performs a fundamental role in GABAergic neurotransmission.

Conclusion

KCTD12 is a multifaceted protein that serves as a key auxiliary factor for GABA_B receptors in the brain and has context-dependent roles in cell signaling and cancer biology. Its BTB/POZ domain-driven tetramerization and specific protein interactions enable it to modulate receptor trafficking, signal transduction kinetics, and intracellular pathways like ERK and AKT. In neurons, KCTD12 fine-tunes inhibitory synaptic transmission – effectively balancing the strength and duration of GABA_B signals. Beyond the brain, KCTD12’s influence on pathways that govern cell proliferation and differentiation has made it a subject of interest in oncology, where it can act as either a brake or an accelerator on tumor growth depending on the cellular context.

Recent research (especially from 2021–2023) has expanded our understanding of KCTD12’s functions, from high-resolution structures explaining its mechanism, to clinical data establishing it as a prognostic biomarker in cancers. Expert analyses concur that KCTD12 is an important regulatory hub at the intersection of neurotransmission and cell signaling (biosignaling.biomedcentral.com) (biosignaling.biomedcentral.com). Its precise roles are still being elucidated, but evidence so far positions KCTD12 as an inhibitor of pathological cell behaviors (like unchecked proliferation and metastasis in certain tumors) and as a modulator of neural inhibition with relevance to stress and mood regulation. Moving forward, KCTD12 represents a promising target or marker in both neurological disorders and oncology. Continued studies into how KCTD12’s BTB domain selects its partners, how its expression is regulated (e.g. developmental and tissue-specific cues), and how it can be modulated by drugs or mutations will provide deeper insights. This will not only clarify the fundamental biology of BTB-domain proteins but could also lead to novel therapeutic strategies that harness the unique modulatory functions of KCTD12 in human health and disease.

References: (Key sources are recent and authoritative)

• Schwenk et al., Nature (2010) – Identified KCTD12/8/16 as auxiliary subunits of native GABA_B receptors (journals.plos.org).
• Tureček et al., J. Neurosci. (2014) – Described kinetic effects of KCTD12 on GABA_B currents (fast desensitization).
• Gilchrist et al., J. Biol. Chem. (2013) – Showed KCTD12 enhances GABA_B surface expression and signaling (pubmed.ncbi.nlm.nih.gov).
• Smaldone et al., PLOS One (2015) – Demonstrated that KCTD12’s BTB domain does not bind Cullin3, distinguishing cullin-dependent vs independent KCTDs (journals.plos.org) (journals.plos.org).
• Maestro et al., Nature (2019) – Solved structural basis for KCTD12-mediated GABA_B signal desensitization (www.nature.com) (www.nature.com).
• Li et al., Sci. Rep. (2016) – Reported KCTD12 suppresses colorectal cancer stemness via ERK pathway; low KCTD12 predicts worse CRC survival (www.nature.com) (www.nature.com).
• Ye et al., Transl. Cancer Res. (2021) – Linked low KCTD12 to poor breast cancer outcomes and immune evasion (biosignaling.biomedcentral.com).
• Taghehchian et al., BMC Cancer (2018) – Noted KCTD12 downregulation in ESCC and tumor-suppressive effects.
• Zhong et al., Oncogene (2017) – Found KCTD12 can promote G2/M transition via CDK1/CDC25B in some cancers (biosignaling.biomedcentral.com).
• De Smaele et al., Cell Commun. Signal. (2021) – Comprehensive review on KCTD proteins in cancer (summarizes KCTD12’s dual roles) (biosignaling.biomedcentral.com) (biosignaling.biomedcentral.com).
• Pan-Cancer Analysis by Chi et al., Sci. Rep. (2023) – Latest data on KCTD12 expression across cancers and correlation with immune infiltration (www.nature.com) (www.nature.com).

All the above sources and data points converge on the depiction of KCTD12 as a critical BTB-domain adaptor protein with specialized roles in GABA_B receptor function and significant implications in human diseases ranging from neurological disorders to cancer. The ongoing research continues to refine this understanding, making KCTD12 an exciting subject in functional genomics and molecular medicine.

Citations

1. AnnotationURLCitation(end_index=512, start_index=300, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
2. AnnotationURLCitation(end_index=973, start_index=817, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=The%20KCTD%20family%20arose%20from,15')
3. AnnotationURLCitation(end_index=1236, start_index=1074, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=evolutive%20divergence%20and%20share%20a,15')
4. AnnotationURLCitation(end_index=1500, start_index=1308, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=match%20at%20L268%20The%20circular,proteins%20assumed%20a%20tetrameric%20organization')
5. AnnotationURLCitation(end_index=1889, start_index=1729, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=a%2C%20Ribbon%20representation%20of%20the,H1%7D%20subunits%20%28green%20and%20cyan')
6. AnnotationURLCitation(end_index=2372, start_index=2189, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=pfetin%2C%20C13orf2%2C%20and%20PFET1%2C%20is,levels%20in%20the%20brain%20and')
7. AnnotationURLCitation(end_index=2538, start_index=2373, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94')
8. AnnotationURLCitation(end_index=2839, start_index=2627, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
9. AnnotationURLCitation(end_index=3143, start_index=2960, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=pfetin%2C%20C13orf2%2C%20and%20PFET1%2C%20is,levels%20in%20the%20brain%20and')
10. AnnotationURLCitation(end_index=4201, start_index=4077, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=12,View%20Article')
11. AnnotationURLCitation(end_index=4494, start_index=4329, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94')
12. AnnotationURLCitation(end_index=4816, start_index=4654, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=proteins%20,pronounced%20desensitization%20of%20the%20K')
13. AnnotationURLCitation(end_index=5132, start_index=5006, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=GABA,thereby%20increases%20the%20magnitude%20of')
14. AnnotationURLCitation(end_index=5363, start_index=5237, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=receptors%20associate%20with%20KCTD12%20while,B')
15. AnnotationURLCitation(end_index=5939, start_index=5775, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=influence%20maturation%20of%20the%20receptor,receptors%20at%20the%20neuronal%20plasma')
16. AnnotationURLCitation(end_index=6595, start_index=6432, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=remains%20associated%20with%20the%20receptor,of%20the%20auxiliary%20subunit%20KCTD12')
17. AnnotationURLCitation(end_index=6983, start_index=6807, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=constitutive%20receptor%20internalization%20and%20thereby,of%20the%20auxiliary%20subunit%20KCTD12')
18. AnnotationURLCitation(end_index=7506, start_index=7343, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=distribution%20to%20axons%20and%20dendrites,association%20with%20KCTD12%20does%20not')
19. AnnotationURLCitation(end_index=7690, start_index=7507, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=pfetin%2C%20C13orf2%2C%20and%20PFET1%2C%20is,levels%20in%20the%20brain%20and')
20. AnnotationURLCitation(end_index=8038, start_index=7876, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=proteins%20,pronounced%20desensitization%20of%20the%20K')
21. AnnotationURLCitation(end_index=8265, start_index=8173, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=G%CE%B1_,stain')
22. AnnotationURLCitation(end_index=8374, start_index=8266, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
23. AnnotationURLCitation(end_index=8667, start_index=8559, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
24. AnnotationURLCitation(end_index=8838, start_index=8668, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2')
25. AnnotationURLCitation(end_index=9138, start_index=8976, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=proteins%20,pronounced%20desensitization%20of%20the%20K')
26. AnnotationURLCitation(end_index=9389, start_index=9229, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=a%2C%20Ribbon%20representation%20of%20the,H1%7D%20subunits%20%28green%20and%20cyan')
27. AnnotationURLCitation(end_index=9859, start_index=9696, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=distribution%20to%20axons%20and%20dendrites,association%20with%20KCTD12%20does%20not')
28. AnnotationURLCitation(end_index=10944, start_index=10784, title='Genome-wide association analysis reveals KCTD12 and miR-383-binding genes in the background of rumination | Translational Psychiatry', type='url_citation', url='https://www.nature.com/articles/s41398-019-0454-1#:~:text=hit%20emerged%20at%20the%20SNP,transdiagnostic%20nature%20of%20rumination%2C%20and')
29. AnnotationURLCitation(end_index=11202, start_index=11044, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=of%20KCTD12%3A%20insights%20into%20interaction,26%2C%20488%E2%80%93495%20%282013')
30. AnnotationURLCitation(end_index=11628, start_index=11434, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=to%20investigate%20behavioral%20responses%20to,suppressing%20the%20excess%20expression%20of')
31. AnnotationURLCitation(end_index=11819, start_index=11629, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=increased%20the%20expression%20of%20Kctd12,suppressing%20the%20excess%20expression%20of')
32. AnnotationURLCitation(end_index=12278, start_index=12091, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=The%20effects%20of%20Kctd12%2C%20an,mood%20disorders%20like%20depression%20treatment')
33. AnnotationURLCitation(end_index=12929, start_index=12737, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=match%20at%20L268%20The%20circular,proteins%20assumed%20a%20tetrameric%20organization')
34. AnnotationURLCitation(end_index=13312, start_index=13142, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2')
35. AnnotationURLCitation(end_index=13621, start_index=13462, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=a%2C%20KCTD16_,down%20with%20glutathione%E2%80%93sepharose%20beads.%20Glutathione')
36. AnnotationURLCitation(end_index=14283, start_index=14129, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do')
37. AnnotationURLCitation(end_index=14436, start_index=14284, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=heat%20exchanges%20upon%20titration%20of,This')
38. AnnotationURLCitation(end_index=14811, start_index=14657, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do')
39. AnnotationURLCitation(end_index=14936, start_index=14812, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=https%3A%2F%2Fdoi')
40. AnnotationURLCitation(end_index=15924, start_index=15805, title='KCTD12 modulation of GABA(B) receptor function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5508304/#:~:text=Introduction%20GABA_,GIRK%2C%20also')
41. AnnotationURLCitation(end_index=16346, start_index=16133, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the')
42. AnnotationURLCitation(end_index=16767, start_index=16554, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the')
43. AnnotationURLCitation(end_index=17125, start_index=16912, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the')
44. AnnotationURLCitation(end_index=17894, start_index=17694, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L518%20KCTD12%20displays,Consistently%2C%20ectopic%20expression%20of')
45. AnnotationURLCitation(end_index=18102, start_index=17895, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of')
46. AnnotationURLCitation(end_index=18624, start_index=18429, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
47. AnnotationURLCitation(end_index=18960, start_index=18765, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
48. AnnotationURLCitation(end_index=19345, start_index=19149, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=levels%20have%20been%20correlated%20with,a%20complex%20that%20supports%20CDK1')
49. AnnotationURLCitation(end_index=21201, start_index=20989, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
50. AnnotationURLCitation(end_index=21385, start_index=21202, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097')
51. AnnotationURLCitation(end_index=21697, start_index=21514, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097')
52. AnnotationURLCitation(end_index=22140, start_index=21967, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=solitary%20fibrous%20tumor%20%20,These%20findings%20suggest%20that')
53. AnnotationURLCitation(end_index=22456, start_index=22299, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=recurrence,diagnosis%20and%20prognosis%20of%20GIST')
54. AnnotationURLCitation(end_index=22739, start_index=22563, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=after%20accounting%20for%20Ki,diagnosis%20and%20prognosis%20of%20GIST')
55. AnnotationURLCitation(end_index=23091, start_index=22908, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097')
56. AnnotationURLCitation(end_index=23571, start_index=23425, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=CD44%2C%20CD133%20and%20CD29%2C%20by,this%20report%20reveals%20that%20KCTD12')
57. AnnotationURLCitation(end_index=23889, start_index=23746, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=CD44%2C%20CD133%20and%20CD29%2C%20by,target%20for%20patients%20with%20CRC')
58. AnnotationURLCitation(end_index=24300, start_index=24145, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=we%20demonstrated%20that%20KCTD12%2C%20potassium,decreased%20level%20of%20KCTD12%20is')
59. AnnotationURLCitation(end_index=24681, start_index=24530, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=using%20a%20colony%20formation%20assay%2C,this%20report%20reveals%20that%20KCTD12')
60. AnnotationURLCitation(end_index=25060, start_index=24911, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20colorectal%20cancer%20,98')
61. AnnotationURLCitation(end_index=25210, start_index=25061, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20colorectal%20cancer%20,98')
62. AnnotationURLCitation(end_index=25804, start_index=25604, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L518%20KCTD12%20displays,Consistently%2C%20ectopic%20expression%20of')
63. AnnotationURLCitation(end_index=26126, start_index=25926, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L518%20KCTD12%20displays,Consistently%2C%20ectopic%20expression%20of')
64. AnnotationURLCitation(end_index=26489, start_index=26282, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of')
65. AnnotationURLCitation(end_index=26881, start_index=26674, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of')
66. AnnotationURLCitation(end_index=27213, start_index=27006, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of')
67. AnnotationURLCitation(end_index=27691, start_index=27547, title='KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8798602/#:~:text=Ribonucleic%20acid,and%20the%20Gene%20Expression%20Profiling')
68. AnnotationURLCitation(end_index=27786, start_index=27692, title='KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8798602/#:~:text=Background')
69. AnnotationURLCitation(end_index=28060, start_index=27916, title='KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8798602/#:~:text=Ribonucleic%20acid,and%20the%20Gene%20Expression%20Profiling')
70. AnnotationURLCitation(end_index=28449, start_index=28315, title='KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration - Wang - Translational Cancer Research', type='url_citation', url='https://tcr.amegroups.org/article/view/48228/html#:~:text=,Biomarker%20of%20Gastrointestinal%20Stromal%20Tumors')
71. AnnotationURLCitation(end_index=28746, start_index=28612, title='KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration - Wang - Translational Cancer Research', type='url_citation', url='https://tcr.amegroups.org/article/view/48228/html#:~:text=,Biomarker%20of%20Gastrointestinal%20Stromal%20Tumors')
72. AnnotationURLCitation(end_index=29044, start_index=28889, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L522%20KCTD12%20in,ESCC')
73. AnnotationURLCitation(end_index=29323, start_index=29168, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L522%20KCTD12%20in,ESCC')
74. AnnotationURLCitation(end_index=29858, start_index=29696, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20in%20human%20uveal%20melanoma,ESCC')
75. AnnotationURLCitation(end_index=30120, start_index=29958, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20in%20human%20uveal%20melanoma,ESCC')
76. AnnotationURLCitation(end_index=30709, start_index=30514, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
77. AnnotationURLCitation(end_index=30906, start_index=30710, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=levels%20have%20been%20correlated%20with,a%20complex%20that%20supports%20CDK1')
78. AnnotationURLCitation(end_index=31381, start_index=31186, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
79. AnnotationURLCitation(end_index=31771, start_index=31576, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
80. AnnotationURLCitation(end_index=32100, start_index=31904, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=levels%20have%20been%20correlated%20with,a%20complex%20that%20supports%20CDK1')
81. AnnotationURLCitation(end_index=32884, start_index=32688, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin')
82. AnnotationURLCitation(end_index=33097, start_index=32885, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
83. AnnotationURLCitation(end_index=33709, start_index=33526, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097')
84. AnnotationURLCitation(end_index=34051, start_index=33878, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=solitary%20fibrous%20tumor%20%20,These%20findings%20suggest%20that')
85. AnnotationURLCitation(end_index=34325, start_index=34168, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=recurrence,diagnosis%20and%20prognosis%20of%20GIST')
86. AnnotationURLCitation(end_index=34641, start_index=34458, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=Abnormal%20expression%20of%20the%20potassium,genomic%20heterogeneity%2C%20and%20diagnostic%20specificity')
87. AnnotationURLCitation(end_index=34783, start_index=34642, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=levels%20decreased%20in%20most%20tumors,KCTD12%20showed%20high')
88. AnnotationURLCitation(end_index=35106, start_index=34951, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=using%20The%20Cancer%20Genome%20Atlas,of%20KCTD12%20decreased%20in%20several')
89. AnnotationURLCitation(end_index=35496, start_index=35355, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=levels%20decreased%20in%20most%20tumors,KCTD12%20showed%20high')
90. AnnotationURLCitation(end_index=35832, start_index=35673, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=tumors%2C%20such%20as%20S200%20and,stemness%2C%20tumor%20burden%2C%20and%20other')
91. AnnotationURLCitation(end_index=36556, start_index=36366, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=increased%20the%20expression%20of%20Kctd12,suppressing%20the%20excess%20expression%20of')
92. AnnotationURLCitation(end_index=36753, start_index=36557, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=acute%20stress%20and%20increased%20vulnerability,suppressing%20the%20excess%20expression%20of')
93. AnnotationURLCitation(end_index=37317, start_index=37123, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=to%20investigate%20behavioral%20responses%20to,suppressing%20the%20excess%20expression%20of')
94. AnnotationURLCitation(end_index=37923, start_index=37765, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L533%20inhibition%20of,102')
95. AnnotationURLCitation(end_index=38273, start_index=38091, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20KCTD12%20to%20esophageal%20squamous,2018%3B18%281%29%3A853')
96. AnnotationURLCitation(end_index=39086, start_index=38931, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=we%20demonstrated%20that%20KCTD12%2C%20potassium,decreased%20level%20of%20KCTD12%20is')
97. AnnotationURLCitation(end_index=39236, start_index=39087, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20colorectal%20cancer%20,98')
98. AnnotationURLCitation(end_index=39668, start_index=39560, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
99. AnnotationURLCitation(end_index=39839, start_index=39669, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2')
100. AnnotationURLCitation(end_index=40304, start_index=40121, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=Abnormal%20expression%20of%20the%20potassium,genomic%20heterogeneity%2C%20and%20diagnostic%20specificity')
101. AnnotationURLCitation(end_index=40608, start_index=40440, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=using%20The%20Cancer%20Genome%20Atlas,significantly%20associated%20with%20the%20prognosis')
102. AnnotationURLCitation(end_index=40750, start_index=40609, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=levels%20decreased%20in%20most%20tumors,KCTD12%20showed%20high')
103. AnnotationURLCitation(end_index=41384, start_index=41246, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=correlations%20with%20tumor%20stage%20and,PAAD%29%2C%20lung')
104. AnnotationURLCitation(end_index=41531, start_index=41385, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=tumors%2C%20such%20as%20S200%20and,may%20be%20involved%20in%20tumor')
105. AnnotationURLCitation(end_index=42182, start_index=41986, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin')
106. AnnotationURLCitation(end_index=42591, start_index=42426, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94')
107. AnnotationURLCitation(end_index=42804, start_index=42592, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
108. AnnotationURLCitation(end_index=43385, start_index=43220, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94')
109. AnnotationURLCitation(end_index=43540, start_index=43386, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do')
110. AnnotationURLCitation(end_index=44048, start_index=43878, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2')
111. AnnotationURLCitation(end_index=44157, start_index=44049, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
112. AnnotationURLCitation(end_index=44538, start_index=44430, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
113. AnnotationURLCitation(end_index=47424, start_index=47228, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin')
114. AnnotationURLCitation(end_index=47638, start_index=47425, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the')
115. AnnotationURLCitation(end_index=48775, start_index=48651, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=12,View%20Article')
116. AnnotationURLCitation(end_index=49194, start_index=49031, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=remains%20associated%20with%20the%20receptor,of%20the%20auxiliary%20subunit%20KCTD12')
117. AnnotationURLCitation(end_index=49505, start_index=49351, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do')
118. AnnotationURLCitation(end_index=49658, start_index=49506, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=heat%20exchanges%20upon%20titration%20of,This')
119. AnnotationURLCitation(end_index=49890, start_index=49782, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
120. AnnotationURLCitation(end_index=50061, start_index=49891, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2')
121. AnnotationURLCitation(end_index=50360, start_index=50209, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=using%20a%20colony%20formation%20assay%2C,this%20report%20reveals%20that%20KCTD12')
122. AnnotationURLCitation(end_index=50504, start_index=50361, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=CD44%2C%20CD133%20and%20CD29%2C%20by,target%20for%20patients%20with%20CRC')
123. AnnotationURLCitation(end_index=50827, start_index=50620, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of')
124. AnnotationURLCitation(end_index=51248, start_index=51053, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
125. AnnotationURLCitation(end_index=51581, start_index=51385, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin')
126. AnnotationURLCitation(end_index=51794, start_index=51582, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
127. AnnotationURLCitation(end_index=52113, start_index=51945, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=using%20The%20Cancer%20Genome%20Atlas,significantly%20associated%20with%20the%20prognosis')
128. AnnotationURLCitation(end_index=52260, start_index=52114, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=tumors%2C%20such%20as%20S200%20and,may%20be%20involved%20in%20tumor')